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The N-terminal domain of thrombospondin-1 (TSPN-1)
mediates the protein’s interaction with (1) glycosami-
noglycans, calreticulin, and integrins during cellular
adhesion, (2) low-density lipoprotein receptor-related
protein during uptake and clearance, and (3) fibrino-
gen during platelet aggregation. The crystal structure
of TSPN-1 to 1.8 A˚ resolution is a b sandwich with 13
antiparallel b strands and 1 irregular strand-like seg-
ment. Unique structural features of the N- and C-termi-
nal regions, and the disulfide bond location, distin-
guish TSPN-1 from the laminin G domain and other
concanavalin A-like lectins/glucanases superfamily
members. The crystal structure of the complex of
TSPN-1 with heparin indicates that residues R29,
R42, and R77 in an extensive positively charged patch
at the bottom of the domain specifically associate with
the sulfate groups of heparin. The TSPN-1 structure
and identified adjacent linker region provide a struc-
tural framework for the analysis of the TSPN domain
of various molecules, including TSPs, NELLs, many
collagens, TSPEAR, and kielin.
Introduction
The thrombospondins (TSPs) comprise a family of extra-
cellular glycoproteins that regulates cellular behavior
during tissue genesis and repair (Adams and Lawler,
2004; Bornstein et al., 2004; Bornstein and Sage,
2002). TSP-1 is the most extensively characterized
member of the family because it was the first to be iden-
tified and is readily purified from human blood platelets.
TSP-1 null mice exhibit defects in activation of trans-
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bidmc.harvard.edu (J.L.)forming growth factor b (TGFb) and wound healing
(Bornstein et al., 2004; Lawler and Detmar, 2004; Lawler
et al., 1998). In addition, TSP-1 and -2 double null mice
have fewer synapses (Christopherson et al., 2005).
These diverse functions of TSP-1 are mediated by its in-
teraction with a wide variety of proteins and proteogly-
cans in the extracellular environment and at the cell sur-
face (Chen et al., 2000). The binding sites for proteins
and proteoglycans are distributed throughout the vari-
ous domains that comprise TSP-1 (Chen et al., 2000).
In some cases, similar structural and functional domains
are present in the other members of the TSP gene family.
All TSP family members, except cartilage oligomeric ma-
trix protein (COMP or TSP-5) have a domain of approxi-
mately 200 amino acids at their N terminus. This domain
of TSP-1, designated TSPN-1, has been found to (1) bind
glucosaminoglycans with high affinity, (2) mediate the
uptake and clearance of TSP-1, and (3) have antiadhe-
sive activity. The TSPN domain is also found in neuronal
NELL proteins (Kuroda et al., 1999), many collagens
(Moradi-Ameli et al., 1994), TSPEAR (Scheel et al.,
2002), and kielin (Matsui et al., 2000). In general, this do-
main is at the N terminus of these large matrix proteins
and is followed by an a-helical region that mediates mul-
timerization. In many of these molecules, the TSPN do-
main appears to be involved in proteoglycan binding.
TSPN-1 is readily cleaved from the intact molecule by
proteases. Some proteolytic release of the N-terminal
domain occurs within the a granules of platelets before
secretion of the protein (Damas et al., 2001). Since sev-
eral platelet proteins bind to heparin-Sepharose, early
purification schemes for TSP-1 sought to separate these
proteins from TSP-1 on immobilized heparin. These
studies revealed that TSPN-1 binds to heparin with high
affinity. The affinity of intact TSP-1 for heparin (Kd =
41 nM) is higher than that of TSPN-1 (Kd =w850 nM) pro-
duced by tryptic digestion (Wang et al., 2004). Intact
TSP-1 also binds to heparan sulfate, dermatan sulfate,
and chondroitin sulfate (Herndon et al., 1999; Merle
et al., 1997). The dermatan sulfate binding site has
been mapped to amino acids 61–95 of TSPN-1 and is in-
volved in the interaction of TSP-1 with decorin (Merle
et al., 1997). In addition to decorin, TSP-1 reportedly
binds to syndecan-1, -3, and -4, perlecan, and cerebro-
glycan (Ferrari do Outeiro-Bernstein et al., 2002; Hern-
don et al., 1999).
The N-terminal domains of TSP-1 and -2 mediate their
uptake and clearance (Wang et al., 2004). This process
appears to involve a proteoglycan and LRP. LRP is
a member of the low-density lipoprotein (LDL) receptor
family, and very low-density lipoprotein (VLDL) receptor
can mediate TSP-1 uptake in LRP-deficient cells (Mi-
khailenko et al., 1997). The LRP binding site is included
in the first 90 amino acids of TSPN-1 (Wang et al., 2004).
Since matrix metalloproteases (MMP) bind to TSP-1 and
-2, they can be taken up along with TSP-1. This process
has been shown to be important for the regulation of ex-
tracellular MMP activity (Yang et al., 2001).
Various cell types attach and form focal adhesion
on fibronectin. These structures are disrupted when
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17–35 of TSPN-1 are added to the cells (Murphy-Ullrich
et al., 1993). The binding of TSP-1 to cell surface calreti-
culin results in the recruitment of LRP and heterotrimeric
G protein to the complex (Orr et al., 2002). This complex
stimulates phosphoinositide 3-kinase, focal adhesion
kinase, and ERK signaling and leads to a disruption of
focal adhesions. The interaction of TSP-1 with calreticu-
lin has recently been found to mediate T cell motility (Li
et al., 2005).
To better understand the function of TSPN-1, we have
determined the structures of TSPN-1 and its complex
with a synthetic pentameric heparin (Arixtra) by X-ray
crystallography. In this paper, we report the globular
b sandwich structure of TSPN-1 that can be classified
as a member of the concanavalin A-like lectins/gluca-
nases superfamily and has some unique features. We
also provide data on how TSPN-1 binds to heparins,
and we review binding of some other proposed ligands
of TSPN-1. We also discuss the relevance of the
TSPN-1 structure to the TSPN domains of other TSP
family members and related TSPN-containing proteins.
Results
The Structure of TSPN-1
The globular TSPN-1 domain has a b sandwich structure
(Figure 1A) and can be classified as a member of the
concanavalin A-like lectins/glucanases superfamily ac-
cording to the Structural Classification of Protein
(SCOP) (Murzin et al., 1995). A structure in this super-
family generally consists of two antiparallel b sheets,
a concave front sheet, and a convex back sheet with
12–14 strands in total. The concave sheet is the hallmark
of the molecules in this superfamily, of which many
members bind carbohydrates through a cleft-like motif
on the front sheet. The TSPN-1 domain has a somewhat
different architecture than the typical b sandwich struc-
ture, consisting of 13 antiparallel b strands and 1 irregu-
lar strand-like segment (colored in purple) (Figure 1A).
This irregular structural segment (including residues
P50PVP) forms the right edge of the domain and is
a unique feature of the N-terminal region of TSPN-1 (Fig-
ure 1B). This proline-rich motif occupies a position of
a b strand that is conserved in all other similar b sand-
wich structures. The replaced b strand is generally anti-
parallel to strand b13 and forms part of a jellyroll-like
structure together with strands b3, b5, b6, b7, b10, b13,
and b14. In many similar b sandwich structures, a
jellyroll-like conformation is formed by eight b strands
on the right side of the domain. In TSPN-1, the irregular
structural segment (designated as b40 hereafter) shifts
away from strand b13 and makes only one direct main
chain-to-main chain hydrogen bond with the b13 strand.
In addition, several water-mediated hydrogen bonds
between strands b13 and b40 are observed (Figure 1B).
Three of them are conserved and well defined in the
native structure and the TSPN-1/Arixtra complex dis-
cussed below. The irregularity of the b40 strand makes
the already imperfect jellyroll-like structure less defined
in TSPN-1. On the left side of the domain, strands of both
b sheets are in a more regular up-and-down topology.
There are six a helices in TSPN-1 (Figure 1A). They are
located either between b strands or at the C-terminal re-gion. Among these helices, a3, crossing over the top of
the two b sheets, is the most prominent. Parallel to a3
are two connected short helices, a4 and a5. Two resi-
dues between them, R171 and D172, noticeably pro-
trude upward (not shown in the figure). The interactions
of all three helices (a3, a4, and a5) with the b sheets are
predominantly hydrophobic. We cannot identify a cal-
cium binding site on the top of the molecule like that ob-
served in laminin G-like domain structures (Rudenko
et al., 2001). The a6 helix is located at the C terminus
and runs parallel to the b strands (Figure 1A). A disulfide
bond is formed between C214 at the end of the a6 helix
and C153 in the b11-b12 loop. This disulfide bond brings
the C terminus into close proximity to the rest of the
TSPN-1 domain.
A Dali structurehomolog search (http://www.ebi.ac.uk/
dali) gave many hits from the concanavalin A-like lectins/
glucanases superfamily. The top hits (Z > 10) include the
leech intramolecular trans-sialidase (PDB: 2SLI), serum
amyloid p component (SAP) (PDB: 1SAC), tetanus neu-
rotoxin (PDB: 1A8D), and calnexin (PDB: 1JHN). How-
ever, in these structure alignments, only about 72.6%–
81.7% of the residues from TSPN-1 can be aligned. Most
of them are from the middle strands of the two b sheets.
The strands along the edges, especially on the right
edges, vary from structure to structure, showing the
complex topologies of the members in this superfamily.
Carbohydrates bind to a cleft-like motif in the concave
front sheet of the lectins. In TSPN-1, the cleft-like motif
is partially covered on the right side by the loop between
the b13 and b14 strands (Figure 1A). The cleft-like motif
is further obscured by side chains from the b6 (E90)
and b7 strands (Q97), which form hydrogen bonds with
the loop between the b13 and b14 strands to stabilize
it (Figure 1B).
Calculation of the electrostatic potential of TSPN-1
identifies a major positively charged surface patch at
the bottom of the domain (Figure 2). A cluster of basic
residues including R29, K32, R42, R77, K80, K81, and
K106 contributes to this extended positively charged re-
gion (Figure 2B). A smaller patch of positive charge on
the top of TSPN-1 includes R65, K68, and R171. Most
of these basic residues have their side chains projecting
into the solvent. Whereas these residues are well sepa-
rated in the primary sequence, they congregate to form
potential heparin binding sites as discussed below. On
the right side of the domain, residues K92, R178, R180,
and K183 form another cluster of basic amino acids.
However, most of these residues are involved in intra-
molecular salt bridges and/or hydrogen bonds and
may not be available for heparin binding (Figure 1B).
The Structure of TSPN-1/Arixtra
Arixtra (fondaparinux sodium) is a synthetic, modified
pentameric heparin (Bauer, 2003) (Figure 3A). It binds
to antithrombin III (ATIII) and potentiates the neutraliza-
tion of Factor Xa. In this study, we used Arixtra as a well-
characterized, homogeneous heparin species for co-
crystalization with TSPN-1 to study heparin binding.
In the TSPN-1/Arixtracomplex, the structure of TSPN-1
is very similar to that of its native unligated form. A super-
position of the two structures gives a root-mean-square
deviation (rmsd) of 0.69 A˚. The major deviation between
the two structures is found in the position of the loop
The Structure of the N-Terminal Domain of TSP-1
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(A) A stereoview of a ribbon diagram of the structure of TSPN-1. The b strands and a helices are colored in cyan and green, respectively. The
irregular proline-rich strand-like segment discussed in the text is labeled as b40 and is highlighted in purple. The sole disulfide bond (yellow)
is drawn in ball-and-stick representation. The jar handle-like motif after the b13 strand is highlighted in yellow. The N and C termini are labeled
as N and C, respectively. The molecule is oriented so that its concave b sheet or front sheet faces the reader. This figure was prepared with the
program MOLSCRIPT (Kraulis, 1991).
(B) A stereoview of the Ca tracing diagram of the front-sheet, right-side strands of TSPN-1. The diagram displays most of the interactions involved
with the irregular strand-like segment b40 colored in purple, interactions with strand b13 and the following jar handle-like motif colored in yellow,
as well as a few interactions from strands b6 and b7 and the loop between them. Three water molecules between b40 and b13 are colored green
and are labeled as W1, W2, and W3. They are conserved in both native and TSPN-1/Arixtra structures and are well defined in electron densities.
Another water molecule, W4, potentially involved in stabilizing the jar handle motif conformation is also drawn in green.(composed of residues G20AARKG) between thea1 helix
and the b2 strand, which is not well-defined by electron
densities in the TSPN-1 native structure. If these six res-
idues are not included in the superposition, the resulting
rmsd is 0.45 A˚. The superposition suggests that there
are no significant conformational changes in TSPN-1
due to the association with Arixtra except for this loop,
which is close to the major heparin binding site and has
been suggested to be one of the GAG binding sites ofTSPN-1 (Lawler et al., 1992). The pentameric and polyca-
nionic nature of Arixtra renders the molecule rather flex-
ible with multiple potential binding sites. In the TSPN-1/
Arixtra complex structure, either owing to the partial
disorder or multiple binding modes, Arixtra does not
appear as a well-defined molecule. Nevertheless, bulky
and sometimes clustered electron densities that sur-
round residues R29, R42, and R77 in the large positively
charged region at the bottom of TSPN-1 clearly
Structure
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(A) A stereoview of TSPN-1 with the major positively (blue) and negatively (red) charged residues labeled. A backbone worm is embedded to
show the orientation of the molecule and the positions of the major charged residues. Besides the positively charged patch at the bottom of
the domain, there is a negatively charged patch around the left edge and the back of TSPN-1, where fibrinogen reportedly binds.
(B) A view of the positively charged surface patch and the positions of the residues, which may contribute to heparin binding on the bottom of
TSPN-1. This site is referred to as the major heparin binding site in the text. The orientation of the molecule shown here is related to the one in (A)
by a 260º rotation around the horizontal axis.
These figures were prepared with the program GRASP (Nicholls et al., 1991).represent the bound sulfate groups that are attached
to Arixtra’s different carbohydrate rings (Figures 2 and
3B). We have assigned this area as the major heparin
binding site. These densities can’t be interpreted as wa-
ter molecules or as sulfate groups from the HEPES
buffer, because both the native TSPN-1 and TSPN-1/
Arixtra complex crystals were grown in identical buffer
conditions. For comparison, Figure 3C shows the same
region of the native TSPN-1 structure, where there are
no significant electron densities observed at the as-
signed major heparin binding site. In the five sulfategroups that have been modeled into the complex struc-
ture, three of them, SO(1), SO(2), and SO(3), surround
residue R42. This arginine has well-defined electron den-
sities in both native and complex structures. Its cationic
guanidinium group changes its orientation in the com-
plex structure such that it is positioned in the center of
the triangle formed by the three surrounding anionic sul-
fate groups. The side chain of residue R29 undergoes
a large conformational change, and it is possibly being
pulled by SO(2). Residue R77 also appears to have
a small conformational change to make a directFigure 3. Arixtra Binding in the TSPN-1/Arix-
tra Complex
(A) Chemical structure of Arixtra (fondapar-
inux sodium), C31H43N3Na10O49S8.
(B) A simulated annealing omit map (2Fo2 Fc
at the 1.0s contour level and colored in green)
around the major heparin binding site and the
partially disordered Arixtra molecule. All non-
protein atoms have been removed from the
simulated annealing refinement and map cal-
culation. A SGN unit, which binds to the top of
a symmetry-related molecule (see text), is la-
beled in yellow. The density in the middle on
the left side is from residue R23 of another
symmetry-related molecule. This residue is
on the flexible loop (G20AARKG), which
changes conformation in the TSPN-1/Arixtra
complex. It seems to be involved in an inter-
action with Arixtra in the molecular packing
of the complex, suggesting that the crystal
packing rather than heparin binding may in-
duce the conformational changes in the loop.
(C) The major heparin binding site in unligated
native TSPN-1 with the difference electron
density map (2Fo 2 Fc) contoured at 1.0s
and colored in green.
(D) The partially disordered Arixtra molecule
and the three arginines from the major hepa-
rin binding site. In this drawing, the TSPN-1/
Arixtra model was rotated about 90º for com-
parison of the partial Arixtra model with the
chemical structure of Arixtra in (A).
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The topology of (A) TSPN-1 is compared with
that of (B) CTSP-1 (the C-terminal domain of
TSP-1) (Kvansakul et al., 2004) and (C) a typi-
cal LG (Laminin A G-domain [LG]/Neurexin/
Sex hormone binding globulin [SHBG]) repeat
(Rudenko et al., 2001). For the LG structure,
only the common positions of the b strands
are shown. The disulfide bonds are high-
lighted in yellow. Only b strands (cyan) are la-
beled for comparison. The a helices of TSPN-
1 and CTSP-1 are shown in green. The two
structures can’t be simply superimposed.
The best alignment can only be made with
the middle strands of the back sheet, b14, b5, b10, and b11 of TSPN-1 and b15, b5, b11, and b12 of CTSP-1. Even in this alignment, the b strands
from the two front sheets shift over about one strand and also rotate slightly. The edge strands, especially the N-terminal edge strands, are totally
out of alignment. The front concaved sheet of CTSP-1 is distinctly curved, while that of TSPN-1 is relatively flat.interaction with SO(4). SO(5) seems to be stabilized by
the interaction with a symmetry-related molecule (not
shown in the figure).
The densities for two more SO groups, resembling the
fifth unit of Arixtra or a SGN (N, O6-disulfo-glucosamine)
unit, are found to be associated with residues R65, K78,
and R171 at the top of the molecule. These residues
were thought to form a second minor heparin binding
site, and their association with the putative SGN unit is
shown in the bottom part of Figure 3B. However, from
the molecular packing in the crystal, the SGN unit and
the five SO groups described earlier seem to be from
one single Arixtra molecule (Figure 3D) based on the
intermolecular spacing and the dimension of Arixtra
(Figure 3A). Thus, one Arixtra molecule binds to one
TSPN-1 at the major binding site and also interacts
with a symmetry-related TSPN-1 at the minor binding
site. Since dimerization of TSPN-1 by Arixtra has not
been observed in solution, the basic triplet R65/K78/
R171 may form a weak opportunistic binding site that
helps to pack TSPN-1 molecules into a crystal lattice
during crystallization.
Discussion
TSPN has been classified as one of the unique modules
in extracellular proteins (Bork et al., 1996). It was later
predicted to have a jellyroll-like fold as laminin G-like do-
main (LG), similar to that of pentraxin based on the
hydrophobic residue distribution patterns in their con-
served regions (Beckmann et al., 1998). Although gener-
ally predicted as an antiparallel b sandwich structure for
the conserved region, the correct architecture of the
globular TSPN-1 has only now been revealed in this
study. TSPN-1 has a distinct topology, especially in its
disulfide bond location and its N- and C-terminal regions
in which TSPN-1 differs from LG, pentraxin, and the
other members of the LNS (Laminin A G-domain/Neu-
rexin/Sex hormone binding globulin [SHBG]) repeat fam-
ily (Rudenko et al., 2001) (Figure 4). Within the concanav-
alin A-like lectins/glucanases superfamily of the SCOP
system, the strand organization of TSPN-1 (Figure 4A)
instead is more like that of hydrolases (i.e., trypanosoma
rangeli sialidase [PDB: 1MZ5]), lectins (i.e., griffonia sim-
plicifonia [PDB: 1LED]), neurotoxin (i.e., tetanus toxin
[PDB: 1A8D]), and calnexin (PDB: 1JHN). In these struc-tures, the N-terminal portion contributes the right-edge
strands (Figures 1 and 4A). Thus, the TSPN domain de-
fines a b sandwich structure that is distinct from the lam-
inin G domain. The structure presented here and se-
quence alignment algorithms enable us to examine
other TSPN-containing proteins. Figure 5 shows a TSPN
sequence alignment of human TSP-1, TSP-2, TSP-3,
TSP-4, Drosophila TSP, NELL-1, and NELL-2 (Kuroda
et al., 1999), some collagens (Moradi-Ameli et al.,
1994), and kielin (Matsui et al., 2000) based on the struc-
ture of TSPN-1. Whereas the sequence identity of the
TSPN is relatively low for these proteins, the hydropho-
bicity pattern of key positions that define the b strands
of TSPN-1 is similar in all of the proteins. In addition,
the positions of the two cysteine residues (e.g., C153
and C214 in TSPN-1) that form a disulfide bond are con-
served. There are additional disulfide bonds in the TSPN
domain of some collagens. These data imply that all of
these proteins probably have similar b sandwich struc-
tures in their TSPN domains. Within the TSP family, the
major difference between TSP-1 and -2, and TSP-3
and -4 is the presence of sequence gaps in the latter
two proteins within their TSPNs. The missing sequences
in TSP-3 and -4 suggest that they are likely to lack the
edge b strands 2 and 3, assembling a fold very much
like the intramolecular trans-sialidase (PDB: 2SLI).
TSPEAR (Scheel et al., 2002) is not included in the se-
quence alignment. This protein may represent the first
TSPN-containing protein that exists as a monomer.
The solution of the TSPN-1 structure helps to identify
a unique linker (approximately 30 residues) between the
globular TSPN-1 domain (N1-C214) and the coiled-coil
sequence region that serves as the trimerization site
(Figure 5). This model is consistent with electron micro-
scopic images of TSP-1 in which the globular TSPN-1 re-
gions can appear well-separated from each other and
from the trimerization site (Lawler et al., 1985). The linker
has few predictable secondary structures and is proba-
bly very flexible. The sequence and length of the linker
vary from molecule to molecule within the group of
TSPN-containing proteins. NELLs and Drosophila TSP
are exceptional in that they have short linkers. Including
the linker in sequence alignments of various TSPNs com-
plicates the analysis of the N-terminal region of these
molecules. The TSPN domain is the most N-terminal
domain for various proteins, except in a few of the colla-
gens, such as a1(XVIII), etc. (Moradi-Ameli et al., 1994).
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38Figure 5. The Sequence Alignment of the N-Terminal Domains of Human TSP-1, TSP-2, TSP-3, and TSP-4; NELL-1 and NELL-2; Collagens
a1(XVIII), a1(IX), a1(V), and a1(XI); Xenopus Kielin; and Drosophila TSP
The secondary structures (b strands and a helices) are underlined and are assigned based on the structure of TSPN-1. The irregular, proline-rich
strand-like element is marked by a dashed line. The cysteines are colored in yellow and in red shadow. The basic residues contributing to the
major heparin binding sites in TSPN-1 are marked in yellow shadow. Those hydrophobic and nonhydrophobic residues that contribute to the
core of the TSPN-1 structure or putatively contribute to the cores of other molecule structures are marked in cyan and green shadow, respec-
tively. The RGD triplet in the D-TSP sequence is shadowed in purple. The asparagines that are present within consensus sequences for glyco-
sylation are shown in red. The motif after the last cysteine (e.g., C214 of TSPN-1) in each sequence is colored blue and is assumed to be the linker
between a TSPN domain and a helical region that forms either trimeric or pentameric coiled coils. Only part of the linkers of the collagens a1(V),
a1(XI), and a1(XVIII) are shown.The linker that follows the TSPN domain generally
seems to be flexible and may allow the TSPN domain
to adopt different orientations to facilitate ligand bind-
ing. In many cases, the TSPN domain has been shown
to bind glycosaminoglycans, suggesting that the TSPN
domain may serve to anchor the protein to proteogly-
cans. In this way, the domains in the remainder of the
protein are available for other interactions that might di-
rect the cell differentiation, growth, or migration that is
associated with the TSPN-containing proteins. The
linker may also possess proteolytic cleavage site(s) for
the potential release of the TSPN domain as observed
in TSP-1 (Damas et al., 2001) and a4(V) collagen (Roth-
blum et al., 2004). Proteolytic cleavage in the linker re-
gion may produce fragments that differ functionally
from each other and from the parent molecule. For ex-
ample, the TSPN-1 domain of TSP-1 stimulates angio-
genesis, while the remainder of the protein inhibits an-
giogenesis (for a review, see Lawler and Detmar,
2004). Cleavage of the linker would also be expected
to dissociate the remainder of the molecule from proteo-
glycans. Thus, proteolysis may represent an importantstep in the spatial and temporal regulation of functions
of the TSPN-containing proteins.
In this study, we have identified a major heparin bind-
ing site (including residues R29, K32, R42, R77, K80,
K81, and K106) on the bottom of the globular TSPN-1.
It has been reported that pairwise mutation of R23 and
K24, R28 and R29, or K80 and K81 decreases the affinity
of the intact molecule for heparin (Lawler et al., 1992).
The localization of R29, K80, and K81 to the positively
charged patch on the bottom of the domain is consistent
with the mutagenesis data. Whereas R23 and K24 are
not included in the major heparin binding site at the bot-
tom of the domain, they are in a flexible loop between
the a1 helix and the b2 strand that is in close proximity
to it. In this study, we used the pentameric heparin, Arix-
tra, because it is chemically well-defined and thus more
amenable to crystallization. In the structure of the TSPN-
1/Arixtra complex, sulfate groups are closely associated
with R29, R42, and R77. These data are consistent with
the identification of the bottom of TSPN-1 as the heparin
binding site and the involvement of R29, as suggested
by mutagenesis. The position of R29 shifts significantly
The Structure of the N-Terminal Domain of TSP-1
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that glycosaminoglycan binding could affect the func-
tional activity of this portion of the molecule as dis-
cussed later. Since R42 is positioned between three sul-
fate groups, this residue seems to be especially
important for Arixtra binding, but its role in other heparin
species binding needs further examination. Previous
studies have reported that tetrasaccharide heparins
can bind TSP-1 and TSPN-1, and that the affinity in-
creases with oligosaccharide length up to decasacchar-
ides (Yu et al., 2000; Mulatero et al., 2003). We hypothe-
size that the specific interactions involved in heparin
binding may vary with the length and sulfation of the ol-
igosaccharide, and that some heparin species interact
with K32, K80, K81, and K106, in addition to, or instead
of, R29, R42, and R77. We are currently performing crys-
tallization and mutagenesis studies with longer heparins
to test this hypothesis.
The three basic residues, R29, R42, and R77, are con-
served in TSP-2, suggesting that TSP-1 and -2 may bind
heparin through a similar mechanism. Whereas the spe-
cific amino acids are not well conserved in other TSPN-
containing proteins, homology modeling based on the
TSPN-1 structure presented here and the sequence
alignment of the proteins shown in Figure 5 reveals the
presence of at least one positively charged region in all
cases, primarily on the bottom of the domain (data not
shown). This is particularly true for Drosophila thrombo-
spondin, which contains five positively charged residues
in the region that aligns with R29 and K32 of human
TSPN-1. This is consistent with biochemical data show-
ing that many of these proteins bind heparin (Adams
et al., 2003; Kuroda et al., 1999; Pihlajamaa et al., 2004).
Besides glycosaminoglycans, a wide variety of pro-
tein receptors function to sequester TSP-1 at the cell
surface. The binding sites for some of these receptors
have been mapped to TSPN-1 by using synthetic pep-
tides. For example, peptide data indicate that calreticu-
lin binds to the region that extends from the a1 helix
through the b2 strand (aa 17–35, also designated hep I)
(Murphy-Ullrich et al., 1993). This peptide covers the en-
tire a1-b2 loop region (Figure 1A), which is flexible, ex-
posed, and available for interactions. In this sense, the
peptide may effectively mimic TSPN-1 in its interaction
with calreticulin. Additionally, Arixtra binding, as dis-
cussed above, affects the conformation of R29 in the
a1-b2 loop. It is possible that cell surface proteoglycans
may enhance or inhibit the interaction of TSPN-1 with
calreticulin. The interaction with calreticulin may be con-
fined to TSP-1 and -2 because the binding sequence is
not present in TSP-3 and -4 or in other related molecules
(Figure 5).
The association of TSP-1 with fibrinogen reportedly
mediates platelet aggregation and the association of
platelets with osteosarcoma cells (Bonnefoy et al.,
2001; Voland et al., 2000). Platelet bound fibrinogen re-
portedly binds to TSP-1 that is on the surface of osteo-
sarcoma cells and may facilitate the hematogenous
spread of metastatic cells (Voland et al., 2000). The fi-
brinogen binding site of TSPN-1 has been mapped
with synthetic peptides to a region that includes the
b12 strand and the flanking loops (aa 151–164, also des-
ignated N12/I) (Voland et al., 2000). This region forms the
left edge of the TSPN-1 domain and is solvent accessi-ble (Figure 1A). Since protein-protein interaction inter-
faces are generally of the size of 16006 400A˚2 (Lo Conte
et al., 1999), the residues from strands b9, b11, and the
adjacent loops may also be involved in fibrinogen bind-
ing. Additionally, the electrostatic potential is very neg-
ative (red in Figure 2A) on the left edge of TSPN-1, sug-
gesting that a positively charged surface patch on
fibrinogen may be involved in the interaction.
The proposed fibrinogen binding region partially over-
laps with the reported a4b1 integrin binding sequence
(A159ELDVP) on the loop between the b12 strand and
the a4 helix (Calzada et al., 2004). Synthetic peptide
data also indicate that a3b1 and a6b1 bind to TSPN-1
(Calzada et al., 2003; Krutzsch et al., 1999). The a3b1
binding site maps to the b14 strand that runs along the
back side of TSPN-1. Of the residues that are reportedly
important for binding to a3b1, only R198 is fully exposed
on the surface. The a6b1 binding site maps to the b6
strand and the following loop, and Calzada et al. (2003)
reported that E90 is essential for a6b1 binding. As shown
in Figure 1B, this residue forms salt bridges with R178,
R180, and K183 and with a water-mediated hydrogen
bond. Thus, the structural data indicate that only the
a4b1 site is fully exposed on the surface of TSPN-1.
The data presented here will facilitate the design of
site-directed mutagenesis strategies to confirm biologi-
cal activity of the proposed integrin binding sites within
the context of the correctly folded domain.
The TSPN-1 structure described here, along with the
published structures of the TSRs (Tan et al., 2002), the
procollagen homology region (O’Leary et al., 2004),
and the last three type 3 repeats with the C-terminal do-
main (Kvansakul et al., 2004) begin to provide an atomic
resolution image of TSP-1. These data permit a detailed
comprehension of the structural organization of TSP-1
and its binding sites for proteoglycans, CD36, integrins,
and various other secreted and transmembrane pro-
teins. Through these interactions, the TSPs serve their
regulatory functions during various forms of tissue re-
modeling, including synaptogenesis, angiogenesis,
wound healing, and neoplasia. Initial studies indicate
that the other TSPN-containing proteins may also func-
tion during tissue genesis and remodeling.
Experimental Procedures
Preparation of Recombinant TSPN-1
A recombinant version of TSPN-1 (amino acids 1–240 of human TSP-
1) was prepared by PCR with the full-length cDNA of human TSP-1
as the template. TSPN-1 was made with the forward primer
573htsp1f (50-GATGATCCATGGAACCGCATTCCAGAGTCTGGC-30)
and the reverse primer 574htsp1r (50-GATACCGGTGTTAGTGCGG
ATGGCAGGGCT-30). The PCR product was sequenced and cloned
between the NcoI and the AgeI sites of the vector pMT/BiP V5-
HisA (Invitrogen; Carlsbad, CA). The recombinant protein includes
the vector-derived sequence RSPW at the N terminus and the se-
quence TGHHHHHH at the C terminus. Vector transfection, cell se-
lection, and protein expression and purification were performed as
described previously (Miao et al., 2001). To label the proteins with
selenomethionine (Se-Met), the cells were grown to high density
(w1 3 107/ml) in media (Hyclone) and were then transferred to me-
thionine-free medium for 4 hr. Se-Met (Sigma) was subsequently
added to the medium to a final concentration of 400 mg/l. The cul-
tures were monitored for cell viability and were harvested at 3–5
days. The Se occupancy was estimated to be about 90% based
on mass spectral analysis. All proteins were further purified by
HPLC in protein buffer of 200 mM NaCl and 20 mM HEPES (pH 7.8).
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40Table 1. Crystallographic Statistics
TSPN-1 TSPN-1/Arixtra
Se-Met (1) Se-Met (2)
Native Peak Inflection Peak
Data Collection
Space group P21 P212121 P212121 P212121
Unit cell
a (A˚) 42.812 (1) 42.345 (1) 42.391 (1) 42.404 (1)
b (A˚) 41.899 (1) 53.071 (1) 53.145 (1) 53.054 (1)
c (A˚) 53.458 (1) 92.414 (2) 92.495 (2) 92.723 (2)
a (º) 90 90 90 90
b (º) 100.649 (1) 90 90 90
g (º) 90 90 90 90
Wavelength (A˚) 1.07218 0.97923 0.97937 0.97923
Resolution (A˚) 50–1.8 50–2.2 50–2.2 50–1.9
Number of unique reflections 17,415 19,677a 19,563a 30,776a
Redundancy 6.9 5.3 5.2 4.4
Completeness (%) 99.6 (96.8)b 96.6 (80.7)b 93.6 (55.0)b 96.7 (78.2)b
Rmerge (%) 6.8 (42.7)
b 6.3 (20.8)b 5.5 (27.3)b 6.8 (35.9)b
I/s(I) 32.12 (2.75)b 29.23 (4.06)b 30.09 (2.50)b 27.13 (1.85)b
Phasing
RCullis (anomalous) (%) 81 84
Figure of merit (%) 64.5
Refinement
Resolution 30–1.8 30–1.9
Reflections (work/test) 13,196/1,472 22,461/2,243
Rcrystal/Rfree 23.64/25.89 25.05/27.79
Bond length (A˚)/angle(º) rms deviation
from ideal geometry
0.007/1.6 0.007/1.4
Protein atoms average B value (A˚2),
main chain/side chain
26.275/27.682 33.534/34.576
a Including Bijvoet pairs.
b Last resolution bin.Crystallization
The purified protein was concentrated to about 10–15 mg/ml for
crystallization with the vapor diffusion hanging drop method. Protein
crystals grew from the buffer containing 30% PEG1500 and 0.08 M
NaAc (pH 4.6). Initially, the crystals produced had multiple forms.
The majority of them were very thin plates with the space group of
P1 (unpublished data). Only one chunky crystal with the space group
P21 was obtained. SDS-PAGE of crystal samples indicated that the
crystals were actually formed from partially degraded protein. The
protein degradation, which was likely caused by unknown residual
proteases from the S2 cell expression system, was later detected
within days after its concentration. Mass spectral analysis with
trypsin-treated, repurified, and concentrated TSPN-1 samples sug-
gested that the degradation was between residues C214 and N230.
C214 is present and paired with C153 in the final structure. The loss
of the N-linked glycan that is attached to N230 is consistent with the
mass reduction and the fact that N230 is the only N-linked glycosyl-
ation site in TSPN-1. Limited digestion with a-chymotrypsin (1:100 or
1:400 w/w) was performed with intact TSP-1 for 20 hr at 0ºC and was
stopped by adding 1 mM PMSF. The principal proteolytic fragment
was purified by HPLC or heparin-Sepharose affinity chromatogra-
phy. The mass spectrum of the a-chymotrypsin-treated protein
was very similar to that of the protein formed by the S2 residual pro-
teases. TSPN-1 made by a-chymotrypsin treatment consistently
produced thicker P1 crystals. However, the P1 crystals have an un-
stable lattice and are prone to subtle transformation during heavy
atom soaking, posing an obstacle to the structure determination
by multiple isomorphous replacement.
It was later found that cocrystallization of TSPN-1 and Arixtra,
a synthetic pentameric heparin molecule (Sanofi-Synthelabo,
France), consistently produced larger stable crystals of space group
P212121 under the same crystallization conditions as that for the un-
liganded, native forms. The TSPN-1 and Arixtra were mixed in a 1:2molar ratio prior to crystallization setup. Crystals of the Se-Met-
labeled TSPN-1 with Arixtra were also produced under the same
crystallization conditions, and they were eventually used for initial
phasing.
Data Collection
Diffraction data sets were collected from prefrozen crystals at 100K
at the 19ID beamline of the Structure Biology Center at the Ad-
vanced Photon Source, Argonne National Laboratory. For structure
resolution, the two-wavelength (peak and inflection) inverse-beam
MAD (multiwavelength anomalous diffraction) data sets were col-
lected from one Se-Met-labeled TSPN-1/Arixtra cocrystal (Table 1).
Another labeled TSPN-1/Arixtra cocrystal was used for acquiring
higher-resolution data. Only the peak data set was collected and
used for structure refinement of TSPN-1/Arixtra (Table 1). The native
data for a crystal of space groupP21 were also collected by using the
single chunky crystal (Table 1). They were used only for structure re-
finement. All diffraction data sets were processed and reduced with
the HKL2000 suite (Otwinowski and Minor, 1997).
Structure Determination and Refinement
The structure of the TSPN-1/Arixtra complex was determined by
two-wavelength MAD phasing (Hendrickson, 1991) of a Se-Met-
labeled TSPN-1/Arixtra cocrystal by using the CCP4 suite (CCP4,
1994) (Table 1). Two Se sites were located from anomalous differ-
ence Patterson maps, and they were used for initial phasing. After
density modification with solvent flattening and histogram mapping,
a partial model (including 160 alanines or glycines) was obtained
from an automatic model building trial by using the program Resolve
(Terwilliger, 2003). It was then examined and reassembled into one
molecule through symmetry operations. After sequence fitting and
manual model building with the program O (Jones et al., 1991), about
95% of the structure was built. The refinement of the structure was
The Structure of the N-Terminal Domain of TSP-1
41performed with the CNS program suite (Brunger et al., 1998) (Table
1). The final TSPN-1 model contains 206 amino acid residues, from
N10 to S215. The only region in the model that does not have elec-
tron densities to fit is between residues G185 and V186, and it is
located at the tip of a jar handle-like motif as discussed below.
The C-terminal residues K213GCS and the residues C153EK on the
b9-b10 loop, where the disulfide bond forms, have weak densities.
We can’t precisely define the N- and C-terminal residues of the pro-
tein because they are not seen in the density maps, and they are
likely disordered in the crystals. They are not included in the TSPN-1
structural model. A fraction of Arixtra was built by using the program
O. Since O-sulfate and N-sulfate groups of Arixtra are indistinguish-
able in the structure for the partially disordered molecule, all of them
were modeled as O-sulfate groups and designated SO groups.
The native structure of the TSPN-1 in P21 was solved by using the
refined TSPN-1 structure obtained from the TSPN-1/Arixtra complex
as the search model with the program Molrep in CCP4 suite. The
model rebuilding and final refinement of the structure were done
with the programs O and CNS, respectively (Table 1). In the final na-
tive TSPN-1 model, besides breaking or poor densities observed at
the locations mentioned above in the TSPN-1/Arixtra complex, res-
idues A22RKG, which are on a loop between the a1 helix and the b2
strand also have poor densities.
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